Find an expert

Dr Mohammad Reza Baneshi is a biostatistician with training, work, and research experience in multiple facets of biostatistics and epidemiology. His background includes advanced research on applying statistical procedures to cancer and HIV/AIDS research. Specifically, his main research interests include analysis of time-to-event data, analysis of longitudinal data, and size estimation of stigmatized groups most at risk of HIV/AIDS. He joined the UQ in 2020 and currently works as a biostatistician at the Australian Women and Girls’ Health Research (AWaGHR) Centre, School of Public Health.

Dr Mohammad Reza Baneshi also has an adjunct position as a Professor of Biostatistics at the Kerman University of Medical Sciences, IRAN.

Before joining the UQ, he conducted several national studies in Iran to provide the most up-to-date estimates of the marginalised populations who are at high risk of HIV. He has made substantial contributions in applying size-estimation methods to stigmatized populations such as people with HIV/AIDS, sex workers, men who have had sex with men, and injection drug users. In 2022, he co-authored the reference book of size estimation methods.

Career Summary: I obtained my B. Tech., Dairy Technology degree from SMC College of Dairy Science, Gujarat, India in 2003. I graduated with a PhD degree in dairy chemistry from the University College Cork, Ireland in 2007. After gaining experience as a postdoctoral fellow in the California Polytechnic State University for 2 years, I joined UQ as a research officer in 2010 and was appointed as a lecturer in 2011 and promoted to associate professor in 2021.

I am a milk and bioprocessing expert with significant experience in dairy processing including alternative methods, milk protein structure and functionality, milk product drying systems, and rapid quantification assays of milk biomolecules. My research spans from fundamental milk protein chemistry to physiologically important milk enzymes. I am leading a UQ-QUT alliance with the RBWH, on innovative pasteurisation of breastmilk through NHMRC Ideas and Children Hospital Foundation grants. This aims to translate my dairy research expertise into enhancing nutrition of low-birth-weight babies, as well as improving infant gut microbiota. This has expanded to related research, including alternative pasteurisation of camel milk, a high-value product used as bovine milk alternative for human nutrition. Since 2011, I have led the ‘non-thermal processing research program’ at UQ. I was one of six research theme leaders (food quality) as well as management committee member in an ARC Industry Transformation Research Hub (2014-2020) that involved 26 researchers. I am currently one of the four program leads for the Food and Beverage Accelerator Trailblazer grant ($165 M) led by UQ. I am also leading the education and training program and am part of the steering committee for a Strategic University Reform Fund (SURF) ($6.9 M) from Department of Education, Skills and Employment.

Research interests:

• Alternative processing techniques to preserve milk and milk products: I have led the ‘non-thermal processing research program’ at UQ since 2011, studying non-thermal techniques such as carbon dioxide, pulsed electric field (PEF), and high-pressure processing (HPP) for milk pasteurisation to minimise loss of heat-labile biomolecules (incl. vitamins/minerals) while ensuring microbial safety.
• Non-bovine milk systems: Since 2014, my research on preserving microbial integrity of dairy stream products for longer periods has evolved in exploring non-bovine systems such as human and camel milk. I have developed expert knowledge of their composition, enzymology, bioactive molecules and digestibility.
• Protein structure and functionality: I have led many studies analysing fundamental properties of milk proteins and their interaction with hydrocolloids. I have considerable expertise in studying protein structure, interactions and denaturation and their functional properties applicable to dairy systems such as texture, rheology, tribology, foaming, gelling and emulsifying properties and surface hydrophobicity. Most recently, I have led development of highly sensitive, high-throughput methods to analyse immunoprotective enzyme activities in human, bovine, goat and camel milk.

Publications and contribution to field of research: I have published >150 peer-reviewed research articles and book chapters, >87% in Q1 journals (JCR Journal Rankings). My h-index is 31 (Scopus) and 38 (Google Scholar) (March, 2023). My research demonstrates international reach, being cited across 103 countries (March 2023). I have been cited by authors from 25 different subject areas, which demonstrates the impact of my research beyond my own subject area of Agricultural and Biological Sciences to fields such as of Medicine, Chemical Engineering, Immunology and Microbiology, Social Science, Nursing, Materials Science and Engineering (Mar 2023). My overall Field-Weighted Citation Impact (FWCI) for all subject areas is 1.59 (Mar 2023). I have 4 highly cited papers in the academic field of Agricultural Science (Web of Science, Mar 2023) and 25 publications in the top 10% most cited publications worldwide (field-weighted) (SciVal, Mar 2023). I am ranked as a Top 1% author in the ESI category of Agricultural Sciences. My publications demonstrate impact beyond the scholarly community. Several of my publications have also been cited in patent documents and have outstanding Altmetric scores (top 5%) with numerous social media, news and blog mentions.

Research support: Since joining the UQ, I have been involved in 17 successful funding proposals and has secured significant research funding through competitive grants. I am a CI on grants worth >$183 million. I have been able to attract funding from a variety of sources such as ARC, NHMRC, DESE, Dairy Innovation Australia Limited (DIAL), UniQuest, Children Hospital Foundation, direct commercial sources and the UQ.

Mentoring: Since 2014, I have supervised 27 HDR students (12 as principal advisor) and >60 Coursework Masters/ Honours students. I have has mentored three postdoctoral fellows.

Professional activities: I am a member of Clinical Advisory Board, Australian Red Cross Lifeblood Milk since 2020. I am the Director of Teaching and Learning for UQ’s School of Agriculture and Food Sciences since 2021. I am an editorial board member of Scientific Reports, Foods, and Journal of Dairy Research.

I am an applied and computational topologist; my research is motivated and inspired by real life problems. My main focus is on understanding how shape influences behaviour, which is a common theme arising in the study of many natural systems. I have done my bachelor and master in Pisa (Italy), and my PhD and first postdoc in Oxford (UK). I then moved to Melbourne for my second postdoc, before starting my position at UQ.

Rebecca Barber is a Senior Legal Officer with the Office of International Law, Australian Attorney General’s Department. She was previously a senior research fellow with the Asia Pacific Centre for the Responsibility to Protect, University of Queensland, where among other things she led the development of a Framework for Action for the Responsibility to Protect and a manual for States on the powers of the UN General Assembly to prevent and respond to atrocity crimes. She has published widely on UN Charter law, international peace and security law, state responsibility, international human rights and humanitarian law and the responsibility to protect. Rebecca has received several awards for her research including early career publication prizes from the International and Comparative Law Quarterly (2021) and the Australian and New Zealand Society of International Law (2023) and an Australian Legal Research Award (2022). She serves on the editorial board of the Journal of International Peacekeeping. Rebecca holds a PhD from the School of Law, University of Queensland and undergraduate degrees and a masters degree in public international law from the University of Melbourne. Rebecca previously had a career in international humanitarian assistance and advocacy, with assignments in Africa, South and Southeast Asia and the Pacific.

Dr. Sebastiano Barbieri is Associate Professor and Principal Research Fellow at the Queensland Digital Health Centre, University of Queensland (UQ) and Adjunct Associate Professor at the Centre for Big Data Research in Health, University of New South Wales (UNSW). His work lies at the intersection of machine learning and healthcare, where he develops innovative computational methods to tackle pressing challenges in medicine.

Aiming to improve patient outcomes and streamline clinical workflows, Dr. Barbieri develops machine learning models tailored to real-world healthcare applications. His current research spans risk prediction using electronic medical records, medical image processing, and the safe and effective integration of AI into clinical decision-making processes.

A strong advocate for responsible AI in healthcare, Dr. Barbieri champions the use of emerging technologies such as synthetic data generation and federated learning. These approaches not only enhance data accessibility and privacy but also accelerate the development of robust, data-driven solutions for digital health.

Professor Andrew Barbour is an academic general surgeon who specialises in upper gastrointestinal, pancreatic, melanoma and sarcoma surgery.

On completion of his training, Dr Barbour worked at the Bristol Royal Infirmary as an Upper Gastrointestinal and Hepatobiliary Surgery Fellow and then as a Surgical Oncology Fellow at the Memorial Sloan-Kettering Cancer Centre, New York.

Professor Andrew Barbour specializes in the treatment of oesophageal, gastric, and pancreatic diseases, as well as melanoma and soft tissue tumours. He has expertise in minimally invasive treatments these conditions, including robotic surgery, minimally invasive oesophagectomy, laparoscopic anti-reflux surgery (fundoplication), laparoscopic gastrectomy, and laparoscopic pancreatectomy.

Professor Barbour’s research interests are in the treatment of cancer. His academic interests have encompassed the areas of 1) clinical research, including randomised controlled clinical trials, 2) laboratory based research, including molecular biology pertinent to upper gastrointestinal disease, pancreatic cancer and melanoma, 3) translational research integrating the laboratory and clinical domains, and 4) health-related quality of life and patient reported outcomes research.

As a clinical researcher, Prof Barbour has been active in the conduct of clinical trials at Phase I, II and III levels. He was the Principal Investigator for investigator initiated, multicentre phase II trials in oesophageal (DOCTOR trial) and pancreatic cancer (GAP Trial), funded by the NH&MRC and sponsored by the Australasian Gastrointestinal Trials Group (AGITG). Both of these national trials include biological substudies with tumour tissue and blood banking and subsequent molecular analyses aimed at answering specific questions, including the identification of biomarkers of response to therapy. These studies are aimed at developing personalized, precision therapy for cancer. The DOCTOR trial was the first trial to use PET scans to “tailor” or “personalize” therapy for patients with oesophageal cancer. The GAP trial has shown that pre-operative chemotherapy is a safe strategy for patients with pancreatic cancer. Building on the GAP trial, the AGITG has undertaken the MRFF funded MASTERPLAN clinical trial for pancreatic cancer exploring th e role of stereotactic radiation in pancreatic cancer. Professor Barbour is the Chair of the AGITG Upper GI working party and a member of the AGITG Board.

Prof Barbour is a translational researcher at the School of Medicine, The University of Queensland. He is the head of Surgical Oncology Lab at the School of Medicine. His research has focused on using genomic, epigenomic, mRNA expression and next generation sequencing data to classify oesophageal adenocarcinoma (OAC), pancreatic cancer and melanoma and to identify biomarkers of outcome. His lab team was the first to identify genomic catastrophes as potential drivers for oesophageal adenocarcinoma. In addition, his lab is seeking to identify genetic markers in melanoma that will identify patients at high risk for recurrence following surgery and to identify patients who will benefit from the current exciting advances in treatment for advanced melanoma. His work in melanoma is supported by a Queensland Advancing Clinical Research Fellowship. He was also a member of the Australian Pancreatic Cancer Genome Initiative (APGI) that has published several key studies that have improved our understanding of pancreatic cancer. His lab is currently undertaking studies using next generation sequencing of tumour and circulating tumour DNA. Professor Barbour is the Chief Investigator for the Cancer Evolution Biobank based at the Translational Research Institute. This biobank contains tumour tissue and blood from patients with melanoma, oesophageal or gastric cancer linked to clinical outcomes and supports several research projects.

Jacqui is an experienced Occupational Therapist and Postdoctoral Clinical Researcher with the Child Health Research Centre, at the University of Queensland. She is committed to creating a shift in early childhood intervention where parents are at the centre of therapy, and child outcomes are better optimised by strengthening parent-child interactions. Jacqui is involved in several clinical research projects that focus on supporting parents who have a child with developmental difficulties. She has also developed an innovative and practical training package for early childhood practitioners. This training package supports practitioners to feel confident incorporating a relationship-focused approach in their therapy as a foundation for all other areas of child development.

I am an Associate Professor in Art History in the School of Communication and Arts. My research often focusses on the relationship between contemporary art and time, working across the areas of philosophy, time studies, art history and critical theory. I completed my art history PhD at the University of Melbourne. Prior to joining UQ, I was ARC Senior Research Associate at the University of Melbourne, and have also worked as a curator and editor with various arts institutions.

My books include the monograph Parallel Presents: The Art of Pierre Huyghe (MIT Press, 2012, winner of AAANZ Best Book Prize 2013); the co-edited anthology and now low-key cult classic Making Worlds: Art and Science Fiction (Surpllus, 2013); Pierre Huyghe: TarraWarra International 2015 (catalogue for the first major solo exhibition of Huyghe's work in Australia); Tom Nicholson: Lines Towards Another (IMA and Sternberg Press, 2018); and Robert Smithson: Time Crystals (Monash University Publishing, 2018), the latter published to accompany a major exhibition of works by Robert Smithson that I co-curated with Chris McAuliffe for presentation at the UQ Art Museum and Monash University Museum of Art. My research has been supported by organisations including the Australia Council for the Arts, Creative Australia, Arts Victoria, the Terra Foundation for American Art, City of Melbourne, the Australia Korea Foundation, the Australia Research Council, and the Gordon Darling Foundation, and I also publish widely in arts magazines and exhibition catalogues.

I have presented invited talks on my research at numerous institutions including for the Biennale of Sydney, Mildura Palimpsest Biennale, Wellington City Gallery New Zealand, Marian Goodman Gallery New York, the Australian Center for the Moving Image, Institute of Modern Art Brisbane, Queensland Art Gallery / Gallery of Modern Art Brisbane, the National Gallery of Australia, the National Gallery of Victoria, Gertrude Contemporary, Auckland University of Technology, Institute for Visual Research University of Oxford, Artspace Sydney, and Helsinki Academy of Fine Arts, Finland. In 2013, I was the recipient of a 2013 Art Gallery of New South Wales residential fellowship at the Cité internationale des arts, Paris.

My current work includes research into the histories of queer art in Australia, as part of the KINK research collective, accessible at queeraustralianart.com. In 2024, KINK were appointed as Adjunct Curators to the Institute of Modern Art, Brisbane.

Currently available to supervise art history MPhil and PhD projects: I particularly welcome applications from researchers working in the areas of contemporary art, queer theory, feminisms, science fiction, Australian art, or time studies (or all of the above!).

Kit Barker joined the TC Beirne School of Law in 2006. He was educated at Exeter College, Oxford, where he graduated with first class honours (in 1988) and subsequently completed the BCL (with distinction) in 1991. He was admitted to the Middle Temple Inn of Court as a Harmsworth Scholar and to the Bar of England and Wales in 1990. He is interested in private law as a whole, but specialises in the law of torts and unjust enrichment law and the law's doctrine, philosophical foundations and remedies. More recently, his work has explored the interface between private law and public law and public policy, with a focus on the tortious liability of government, misfeasance in public office and the use of private enforcement techniques in public law. He is a former Associate Dean (Research) at the TC Beirne School of Law and an assistant editor of the Torts Law Journal. He is co-author of three books - Unjust Enrichment (3rd ed, Sydney, Lexis Nexis, Butterworths, 2024, 1st ed, 2008), The Law of Torts in Australia (5th ed, 2011, OUP) and Remedies: Commentary and Materials (Thomson, 2015). He is also an editor and contributor to six essay collections: Life and Death in Private Law (Oxford, Hart Publishing, 2024), Private Law: Key Encounters with Public Law (Cambridge University Press, 2013), The Law of Misstatements (Hart Publishing, 2015); Private Law and Power (Hart Publishing, 2017) ; Private Law in the Twenty-First Century (Hart Publishing, 2017); Apportionment in Private Law (Hart Publishing, 2018) and the Research Handbook on Unjust Enrichment and Restitution (Edward Elgar, 2020).

He is a fellow of the Australian Academy of Law and current director of the Australian Centre of Private Law at the TC Beirne School of Law.

I am an academic paediatric neurologist, clinical researcher, and specialist in acquired brain injury in children and adolescence. I studied at the University of Edinburgh and British Columbia before taking up my first academic position at the University of Calgary in 2002. Here I developed and directed the Traumatic Brain Injury and Concussion Research Program at the Alberta Children's Hospital and where I cemented my interest in the biology and treatment of children with brain injuries. I have extensive clinical research experience, devising and overseeing clinical trials in children both nationally and internationally. I moved to the Child Health Research Centre at the University of Queensland, Australia in October 2017 and joined the Queensland Paediatric Rehabilitation Service and Queensland Cerebral Palsy Rehabililation Centre to facilitate research into improving the health outcomes of children with acquired brain injury in Queensland and Australia.

My research focuses on the neurobiological signatures and treatment of subtle neurological dysfunction in mild traumatic brain injury and concussion, especially the behavioural and cognitive impairments that are found in post-concussion syndrome. I use multimodal neurological assessments to do this. My research explores combining neuroimaging and neurophysiological investigations, including perfusion studies using MRI (ASL-fMRI) and transcranial magnetic stimulation to help us understand the changes in the brain in children who are slow to recovery following a concussion. This is to help us develop and assess more effective and tailored treatments for children with concussion and traumatic brain injury. I explore novel therapies for children with persistent post-concussive symptoms in clinical trials including the use of neuraceuticals, pharmacotherapies, and non-invasive brain stimulation treatment.

I am the director of the newly-established KidStim Lab at the Child Health Research Centre. This is the first non-invasive neuromodulation facility aimed at improving the health outcomes of children with brain injury in Australia and is led by a mulitdisciplinary team of clinicians and scientists from Brisbane bring a unique clinical and scientific knowledge-base to help achieve our goals. Rehabilitation therapy in combination with repetitive transcranial direct current stimulation (rTMS) and other direct current stimulation modalities (e.g. tDCS) will be explored. It also offers the potential for treatment of the mood and behavioural disorders (e.g. depression and anxiety) commonly seen after brain injury but also so disruptive to the life of the normally developing teenager.

Dr Andy Barnes obtained his BSc (Hons) in Microbiology from Heriot-Watt University, Edinburgh and his PhD from the Medical School, University of Edinburgh. Andy worked for the Scottish Office Agriculture and Fisheries Department and at the Moredun Research Institute, Edinburgh before joining a small Canadian biotech company, Aqua Health Ltd, specialising in vaccines for aquaculture in 1993. In 1999, Aqua Health was bought by Swiss pharmaceutical giant Novartis and Andy worked in their animal health division for 4 years before beginning an academic career at The University of Queensland. Currently in the School of Biological Sciences, Andy’s Aquatic Animal Health Lab researches vaccines for the aquaculture industry and investigates health and immunity in aquatic animals ranging from reef-building corals, through prawns and oysters, to barramundi, stingrays and grouper.

Dr Richard Barnes was for 40 years a staff member of the Department of Zoology of the University of Cambridge, UK, and in 'retirement' he remains attached to that Department and an Emeritus Fellow of St Catharine's College Cambridge. In addition, however, for 3 months of each year he functions as an honorary member of staff of the University of Queensland and of Queensland Museum's Biodiversity Program (October - December inclusive), and likewise (January - March inclusive) of the Department of Zoology of Rhodes University, South Africa.

Joel Barnes is Honorary Research Fellow in the School of Historical and Philosophical Inquiry. He works on histories of evolutionary science, education and universities, and has held postdoctoral positions at the University of Technology Sydney and the University of Queensland.

Tony Barnett is a Research Fellow in the School of Psychology, and National Centre for Youth Substance Use Research, University of Queensland. Tony's work explores the social and cultural contexts of alcohol and other drug use, treatment (including novel therapeutic interventions) and policy change. His work draws on critical social science methods to provide in-depth accounts of consumers, carers and clinicians’ experiences of addiction treatment, care and recovery.

In 2020, Tony completed his PhD thesis at Monash University. His work explored clinicians’ views about the brain disease model of addiction and how neuroscientific models and interventions integrate within clinical practice. His research interests include: Qualitative research; Harm reduction; Opioid addiction; Treatment policy, evaluation and outcome monitoring.